128 related articles for article (PubMed ID: 37961226)
1. Missense mutations in Myc Box I influence MYC cellular localization, mRNA partitioning and turnover to promote leukemogenesis.
Arthur NB; Christensen KA; Mannino K; Ruzinova MB; Kumar A; Gruszczynska A; Day RB; Erdmann-Gilmore P; Mi Y; Sprung R; York CR; Reid Townsend R; Spencer DH; Sykes SM; Ferraro F
bioRxiv; 2023 Oct; ():. PubMed ID: 37961226
[TBL] [Abstract][Full Text] [Related]
2. Missense mutations in Myc Box I influence nucleocytoplasmic transport to promote leukemogenesis.
Arthur NB; Christensen KA; Mannino K; Ruzinova MB; Kumar A; Gruszczynska A; Day RB; Erdmann-Gilmore P; Mi Y; Sprung R; York CR; Townsend RR; Spencer DH; Sykes SM; Ferraro F
Clin Cancer Res; 2024 Jun; ():. PubMed ID: 38848040
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
[TBL] [Abstract][Full Text] [Related]
5. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
[TBL] [Abstract][Full Text] [Related]
7. A Germline Point Mutation in the MYC-FBW7 Phosphodegron Initiates Hematopoietic Malignancies.
Freie B; Carroll PA; Varnum-Finney BJ; Ramani V; Bernstein I; Eisenman RN
bioRxiv; 2023 Oct; ():. PubMed ID: 37961183
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
[TBL] [Abstract][Full Text] [Related]
9. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain.
Hoang AT; Lutterbach B; Lewis BC; Yano T; Chou TY; Barrett JF; Raffeld M; Hann SR; Dang CV
Mol Cell Biol; 1995 Aug; 15(8):4031-42. PubMed ID: 7623799
[TBL] [Abstract][Full Text] [Related]
10. A common functional consequence of tumor-derived mutations within c-MYC.
Chakraborty AA; Scuoppo C; Dey S; Thomas LR; Lorey SL; Lowe SW; Tansey WP
Oncogene; 2015 Apr; 34(18):2406-9. PubMed ID: 24998853
[TBL] [Abstract][Full Text] [Related]
11. Molecular synergy underlies the co-occurrence patterns and phenotype of
Dovey OM; Cooper JL; Mupo A; Grove CS; Lynn C; Conte N; Andrews RM; Pacharne S; Tzelepis K; Vijayabaskar MS; Green P; Rad R; Arends M; Wright P; Yusa K; Bradley A; Varela I; Vassiliou GS
Blood; 2017 Oct; 130(17):1911-1922. PubMed ID: 28835438
[No Abstract] [Full Text] [Related]
12. Differential Transcriptional Reprogramming by Wild Type and Lymphoma-Associated Mutant MYC Proteins as B-Cells Convert to a Lymphoma Phenotype.
Mahani A; Arvidsson G; Sadeghi L; Grandien A; Wright APH
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885204
[TBL] [Abstract][Full Text] [Related]
13. N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia.
Peramangalam PS; Surapally S; Veltri AJ; Zheng S; Burns R; Zhu N; Rao S; Muller-Tidow C; Bushweller JH; Pulikkan JA
Sci Adv; 2024 Mar; 10(9):eadh8493. PubMed ID: 38416825
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
[TBL] [Abstract][Full Text] [Related]
15. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
[TBL] [Abstract][Full Text] [Related]
16. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
Su R; Gong JN; Chen MT; Song L; Shen C; Zhang XH; Yin XL; Ning HM; Liu B; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
Oncotarget; 2016 Nov; 7(47):77430-77443. PubMed ID: 27764807
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Radmacher MD; Mrózek K; Vukosavljevic T; Paschka P; Whitman SP; Langer C; Baldus CD; Liu CG; Ruppert AS; Powell BL; Carroll AJ; Caligiuri MA; Kolitz JE; Larson RA; Bloomfield CD
J Clin Oncol; 2008 Nov; 26(31):5078-87. PubMed ID: 18809607
[TBL] [Abstract][Full Text] [Related]
18. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Spensberger D; de Knegt Y; Tang M; Löwenberg B; Delwel R
Oncogene; 2005 Jun; 24(25):4129-37. PubMed ID: 15806161
[TBL] [Abstract][Full Text] [Related]
19. Defective c-myc and c-myb RNA turnover in acute myeloid leukemia cells.
Baer MR; Augustinos P; Kinniburgh AJ
Blood; 1992 Mar; 79(5):1319-26. PubMed ID: 1371419
[TBL] [Abstract][Full Text] [Related]
20. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.
Jones RM; Branda J; Johnston KA; Polymenis M; Gadd M; Rustgi A; Callanan L; Schmidt EV
Mol Cell Biol; 1996 Sep; 16(9):4754-64. PubMed ID: 8756633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
